Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Although tirzepatide did not meet the criterion for superiority to dulaglutide with respect to the primary endpoint, a prespecified subgroup analysis suggested a possible lower incidence of death from any cause and of death from noncardiovascular causes in the tirzepatide group than in the dulaglutide group
[ CrossRef ] [ Google scholar ] [ PubMed ] Perochon J, Carroll LR, Cordero JB
M., Peng, Y., Peng, C
8 , e70490 (2025)
Matsumoto K, Yoshitomi T, Ishimoto Y, Tanaka N, Takahashi K, Watanabe A, et al
Sumithran, P., et al., Long-term persistence of hormonal adaptations to weight loss
US$ 21.44
US$ 27.54
US$ 27.46
US$ 25.06
US$ 29.27
US$ 26.48
US$ 22.40
